Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

121.78
Delayed Data
As of 3:59pm ET
 +3.55 / +3.00%
Today’s Change
94.39
Today|||52-Week Range
127.00
+5.21%
Year-to-Date
Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss
8:56am / Zacks.com - Paid Partner Content
Juno Therapeutics (JUNO) Q4 Earnings: What's in the Cards?
Feb 23 / Zacks.com - Paid Partner Content
Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat
Feb 24 / Zacks.com - Paid Partner Content
Here's Why Celgene's Latest Drug Is So Exciting
Feb 23 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4
Feb 24 / Zacks.com - Paid Partner Content
Go With Allergan, Celgene and 'Big Mo'
Feb 22 / TheStreet.com - Paid Partner Content
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat
Feb 24 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Alexion Reports 4Q Results, Celgene MS Drug Looks Promising
Feb 22 / Zacks.com - Paid Partner Content
3 Incredibly Cheap Biotech Stocks
Feb 24 / MotleyFool.com - Paid Partner Content
3 Great Stocks to Buy Instead of NVIDIA Corporation
Feb 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close118.23
Today’s open118.29
Day’s range118.01 - 122.00
Volume4,220,307
Average volume (3 months)4,701,541
Market cap$92.0B
Dividend yield--
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.41%
Earnings growth (next 5 years)+22.37%
Revenue growth (last year)+22.70%
P/E ratio48.9
Price/Sales8.51
Price/Book13.95

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.88+0.36%
LLYEli Lilly and Co+0.19+0.23%
BMYBristol-Myers Squibb+0.12+0.21%
ABBVAbbVie+0.13+0.21%
Data as of 4:01pm ET, 02/27/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs